# Vivani Medical, Inc.: filings

VANI · Nasdaq · CIK 1266806 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vani.md) · [Financials](/companies/vani/financials.md) · [Filings](/companies/vani/filings.md) · [Insiders](/companies/vani/insiders.md)

## Reports and events: 323 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 336, 8-K 234, 10-Q 35, 3 35, D 19, CORRESP 14, 10-K 12, DEFA14A 11, UPLOAD 11, 424B5 10, DEF 14A 10, EFFECT 10, SC 13D/A 10, S-1/A 7, 424B3 6, S-8 6, SC 13G/A 6, 10-K/A 5, 425 5, SC 13G 5, ARS 4, S-3 4, SC 13D 4, 3/A 3, 5 3, S-1 3, 8-A12B 2, CERTNAS 2, D/A 2, DEFR14A 2, FWP 2, POS AM 2, PRE 14A 2, 10-Q/A 1, 144 1, 25 1, 8-A12B/A 1, 8-K/A 1, ARS/A 1, DEF 14C 1, DEFM14A 1, PRE 14C 1, S-3/A 1, S-4 1, S-4/A 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:30 ET | [8-K](/filings/0001753926-26-002036.md) | 7.01 Regulation FD disclosure | 0001753926-26-002036 |
| 2026-10-29 | 07:30 ET | [8-K](/filings/0001753926-26-002024.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-002024 |
| 2026-09-16 | 16:15 ET | [8-K](/filings/0001753926-26-001808.md) | 7.01 Regulation FD disclosure | 0001753926-26-001808 |
| 2026-08-17 | 08:00 ET | [8-K](/filings/0001753926-26-001536.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001536 |
| 2026-08-13 | 16:31 ET | [8-K](/filings/0001753926-26-001482.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001482 |
| 2026-08-13 | 16:01 ET | [10-Q](/filings/0001753926-26-001477.md) | Quarterly report, period 2026-06-30 | 0001753926-26-001477 |
| 2026-08-06 | 08:15 ET | [8-K](/filings/0001753926-26-001349.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001349 |
| 2026-07-16 | 08:30 ET | [8-K](/filings/0001753926-26-001190.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001190 |
| 2026-07-07 | 07:46 ET | [8-K](/filings/0001753926-26-001144.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001144 |
| 2026-06-30 | 08:03 ET | [8-K](/filings/0001753926-26-001109.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001109 |
| 2026-06-04 | 07:30 ET | [8-K](/filings/0001753926-26-000974.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000974 |
| 2026-05-19 | 13:01 ET | [SCHEDULE 13D/A](/filings/0001753926-26-000912.md) | Ownership report, active investor, amended | 0001753926-26-000912 |
| 2026-05-13 | 16:25 ET | [8-K](/filings/0001753926-26-000854.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000854 |
| 2026-05-13 | 16:24 ET | [10-Q](/filings/0001753926-26-000852.md) | Quarterly report, period 2026-03-31 | 0001753926-26-000852 |
| 2026-04-29 | 16:30 ET | [DEF 14A](/filings/0001753926-26-000750.md) | Proxy statement, period 2025-12-31 | 0001753926-26-000750 |
| 2026-03-26 | 16:36 ET | [8-K](/filings/0001753926-26-000550.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-26-000550 |
| 2026-03-26 | 16:32 ET | [10-K](/filings/0001753926-26-000548.md) | Annual report, period 2025-12-31 | 0001753926-26-000548 |
| 2026-01-27 | 16:11 ET | [8-K](/filings/0001753926-26-000194.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000194 |
| 2025-11-13 | 08:10 ET | [10-Q](/filings/0001753926-25-001770.md) | Quarterly report, period 2025-09-30 | 0001753926-25-001770 |
| 2025-11-13 | 08:00 ET | [8-K](/filings/0001753926-25-001768.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001768 |
| 2025-10-28 | 06:03 ET | [8-K](/filings/0001753926-25-001655.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001655 |
| 2025-10-03 | 08:41 ET | [8-K](/filings/0001753926-25-001582.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001582 |
| 2025-09-17 | 09:27 ET | [8-K](/filings/0001753926-25-001510.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001510 |
| 2025-09-09 | 16:21 ET | [8-K](/filings/0001753926-25-001443.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001443 |
| 2025-09-04 | 16:56 ET | [8-K](/filings/0001753926-25-001431.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001431 |
| 2025-08-13 | 17:01 ET | [10-Q](/filings/0001753926-25-001330.md) | Quarterly report, period 2025-06-30 | 0001753926-25-001330 |
| 2025-08-13 | 16:54 ET | [8-K](/filings/0001753926-25-001328.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001328 |
| 2025-08-05 | 08:20 ET | [8-K](/filings/0001753926-25-001228.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001228 |
| 2025-06-25 | 16:28 ET | [8-K](/filings/0001753926-25-001005.md) | 5.07 Shareholder vote results | 0001753926-25-001005 |
| 2025-06-17 | 06:16 ET | [8-K](/filings/0001753926-25-000966.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000966 |
| 2025-06-11 | 08:45 ET | [8-K](/filings/0001753926-25-000956.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000956 |
| 2025-05-29 | 08:45 ET | [8-K](/filings/0001753926-25-000898.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000898 |
| 2025-05-13 | 16:47 ET | [10-Q](/filings/0001753926-25-000794.md) | Quarterly report, period 2025-03-31 | 0001753926-25-000794 |
| 2025-05-13 | 16:41 ET | [8-K](/filings/0001753926-25-000792.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000792 |
| 2025-04-29 | 08:01 ET | [DEF 14A](/filings/0001753926-25-000694.md) | Proxy statement, period 2025-06-24 | 0001753926-25-000694 |
| 2025-04-15 | 08:45 ET | [8-K](/filings/0001753926-25-000635.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000635 |
| 2025-03-31 | 08:45 ET | [10-K](/filings/0001753926-25-000527.md) | Annual report, period 2024-12-31 | 0001753926-25-000527 |
| 2025-03-31 | 08:40 ET | [8-K](/filings/0001753926-25-000526.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000526 |
| 2025-03-27 | 09:11 ET | [8-K](/filings/0001753926-25-000495.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000495 |
| 2025-03-26 | 07:45 ET | [8-K](/filings/0001753926-25-000488.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000488 |
| 2025-03-13 | 07:40 ET | [8-K](/filings/0001753926-25-000438.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000438 |
| 2024-11-13 | 08:41 ET | [10-Q](/filings/0001753926-24-001874.md) | Quarterly report, period 2024-09-30 | 0001753926-24-001874 |
| 2024-11-13 | 08:36 ET | [8-K](/filings/0001753926-24-001872.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-24-001872 |
| 2024-10-22 | 08:45 ET | [8-K](/filings/0001753926-24-001731.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001731 |
| 2024-09-26 | 08:46 ET | [8-K](/filings/0001753926-24-001628.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001628 |
| 2024-09-23 | 08:15 ET | [8-K](/filings/0001753926-24-001614.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001614 |
| 2024-09-04 | 08:16 ET | [8-K](/filings/0001753926-24-001531.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001531 |
| 2024-08-13 | 16:29 ET | [8-K](/filings/0001753926-24-001422.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-24-001422 |
| 2024-08-13 | 16:20 ET | [10-Q](/filings/0001753926-24-001420.md) | Quarterly report, period 2024-06-30 | 0001753926-24-001420 |
| 2024-07-11 | 08:15 ET | [8-K](/filings/0001753926-24-001236.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001236 |

Page 1 of 7. [Older](/companies/vani/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:40 ET. No prices; not investment advice.